In-vitro activity of a new quinolone (CP-99,219) compared with ciprofloxacin, pefloxacin, azithromycin and penicillin against Neisseria gonorrhoeae

J Antimicrob Chemother. 1995 Jul;36(1):215-8. doi: 10.1093/jac/36.1.215.

Abstract

The in-vitro activities of CP-99, 219, ciprofloxacin, pefloxacin, azithromycin and penicillin was tested against 114 Neisseria gonorrhoeae strains. The MIC90s were: 0.008 mg/L (MIC range 0.001-0.06 mg/L) for CP-99, 219, 0.008 mg/L (MIC range 0.001-0.25 mg/L) for ciprofloxacin, 0.12 mg/L (MIC range 0.008-4 mg/L) for pefloxacin, 0.25 mg/L (MIC range 0.03-1 mg/L) for azithromycin and 16 mg/L (MIC range 0.015-16 mg/L) for penicillin. The activity of CP-99,219 against various N. gonorrhoeae isolates was comparable to ciprofloxacin.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents / pharmacology*
  • Azithromycin / pharmacology
  • Ciprofloxacin / pharmacology
  • Fluoroquinolones*
  • Gonorrhea / microbiology
  • Humans
  • Microbial Sensitivity Tests
  • Naphthyridines / pharmacology*
  • Neisseria gonorrhoeae / drug effects*
  • Pefloxacin / pharmacology
  • Penicillins / pharmacology

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Fluoroquinolones
  • Naphthyridines
  • Penicillins
  • Pefloxacin
  • Ciprofloxacin
  • Azithromycin
  • trovafloxacin